The long-term outlook for patients undergoing RALP is generally positive, with high rates of cancer control and survival. Studies have shown that RALP provides similar oncological outcomes to traditional open surgery but with the added benefits of a minimally invasive approach. Continual follow-up is necessary to monitor for any signs of cancer recurrence and to manage any long-term side effects.
